Increasing hepatitis B vaccination coverage and decreasing hepatitis B co-infection prevalence among people with HIV-1 in Germany, 1996-2019. Results from a cohort study primarily in men who have sex with men
- Published on 11/16/2023
- Reading time: 6 min.
A. Krings 1, D. Schmidt 1, C. Kollan 1, K. Meixenberger 2, N. Bannert 2, D. Münstermann 3, C. Tiemann 3, V. Bremer 1, B. Gunsenheimer‐Bartmeyer 1, the German HIV‐1 Seroconverter Study Group
1
Department of Infectious Disease Epidemiology
Robert Koch Institute
Berlin
Germany
2
Department of Infectious Diseases
Robert Koch Institute
Berlin
Germany
3
MVZ Labor Krone GbR
Bad Salzuflen
Germany
Abstract
Objectives Viral hepatitis co‐infection among people living with HIV is known to accelerate the progression of liver disease and AIDS. An increased prevalence and incidence of hepatitis B virus (HBV) infection among people living with HIV demands continuous monitoring to adapt targeted prevention strategies to reach the global goals of eliminating viral hepatitis as a public health threat.
Methods We determined the prevalence and incidence of HBV...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Infectious Diseases
Receive our newsletter to stay up to date with the latest news in Infectious Diseases
